Placement Completed

Freenome placement

US$240m raised

Announced 5 Dec 2025 · NASDAQ: FRNM · US$10.00 cash per share

Advisers

Freenome

Issuer

Legal adviser

Lead managers

Legal adviser
Placement agent
Issuer
Freenome
Issuer based in
United States
Completed
24 Jul 2026
Sector
Diagnostics
Tags
Diagnostics, Oncology, Life Sciences

Similar deals

All diagnostics deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.